Cme Group Inc. CME
We take great care to ensure that the data presented and summarized in this overview for CME GROUP INC. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding CME
View all-
Vanguard Group Inc Valley Forge, PA33.4MShares$7.12 Billion0.14% of portfolio
-
Black Rock Inc. New York, NY25.5MShares$5.43 Billion0.13% of portfolio
-
Capital International Investors Los Angeles, CA15.8MShares$3.37 Billion0.7% of portfolio
-
State Street Corp Boston, MA15.7MShares$3.35 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY15.1MShares$3.21 Billion0.29% of portfolio
-
Capital World Investors Los Angeles, CA13.2MShares$2.81 Billion0.48% of portfolio
-
Geode Capital Management, LLC Boston, MA7.94MShares$1.69 Billion0.16% of portfolio
-
Morgan Stanley New York, NY5.5MShares$1.17 Billion0.1% of portfolio
-
Parnassus Investments, LLC5.45MShares$1.16 Billion2.58% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN4.75MShares$1.01 Billion0.29% of portfolio
Latest Institutional Activity in CME
Top Purchases
Top Sells
About CME
CME Group Inc., together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income products. The company also provides clearing house services, including clearing, settling, and guaranteeing futures and options contracts, and cleared swaps products traded through its exchanges; and trade processing and risk mitigation services. In addition, the company offers a range of market data services, including real-time and historical data services. It serves professional traders, financial institutions, institutional and individual investors, corporations, manufacturers, producers, governments, and central banks. The company was formerly known as Chicago Mercantile Exchange Holdings Inc. and changed its name to CME Group Inc. in July 2007. CME Group Inc. was founded in 1898 and is headquartered in Chicago, Illinois.
Insider Transactions at CME
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 14
2024
|
Derek Sammann Sr MD Gl Hd Commodity & Option |
BUY
Bona fide gift
|
Indirect |
3,789
+25.95%
|
-
|
|
May 14
2024
|
Derek Sammann Sr MD Gl Hd Commodity & Option |
SELL
Bona fide gift
|
Direct |
3,789
-28.1%
|
-
|
|
May 13
2024
|
Terry L Savage Director |
SELL
Open market or private sale
|
Indirect |
2,500
-12.54%
|
$525,000
$210.65 P/Share
|
|
May 08
2024
|
Hilda Harris Piell Sr MD & Chief HR Officer |
SELL
Open market or private sale
|
Direct |
7,140
-5.22%
|
$1,499,400
$210.37 P/Share
|
|
Apr 29
2024
|
Terrence A Duffy Chairman and CEO |
SELL
Open market or private sale
|
Direct |
40,000
-13.79%
|
$8,400,000
$210.39 P/Share
|
|
Mar 26
2024
|
William R Shepard Director |
BUY
Open market or private purchase
|
Indirect |
282
+0.11%
|
$60,348
$214.71 P/Share
|
|
Mar 26
2024
|
William R Shepard Director |
BUY
Open market or private purchase
|
Direct |
12
+0.51%
|
$2,568
$214.71 P/Share
|
|
Mar 15
2024
|
Timothy Francis Mc Court Sr MD Global Head Equity & FX |
SELL
Payment of exercise price or tax liability
|
Direct |
383
-2.82%
|
$83,111
$217.5 P/Share
|
|
Mar 15
2024
|
Timothy Francis Mc Court Sr MD Global Head Equity & FX |
BUY
Open market or private sale
|
Direct |
556
+7.49%
|
$120,652
$217.5 P/Share
|
|
Mar 15
2024
|
Ken Vroman Chief Transformation Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,449
-5.49%
|
$531,433
$217.5 P/Share
|
|
Mar 15
2024
|
Ken Vroman Chief Transformation Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,292
+19.09%
|
$1,148,364
$217.5 P/Share
|
|
Mar 15
2024
|
Lynne Fitzpatrick Sr MD Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
329
-1.15%
|
$71,393
$217.5 P/Share
|
|
Mar 15
2024
|
Lynne Fitzpatrick Sr MD Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
559
+3.75%
|
$121,303
$217.5 P/Share
|
|
Mar 15
2024
|
Derek Sammann Sr MD Gl Hd Commodity & Option |
SELL
Payment of exercise price or tax liability
|
Direct |
3,014
-18.27%
|
$654,038
$217.5 P/Share
|
|
Mar 15
2024
|
Derek Sammann Sr MD Gl Hd Commodity & Option |
BUY
Grant, award, or other acquisition
|
Direct |
6,803
+29.2%
|
$1,476,251
$217.5 P/Share
|
|
Mar 15
2024
|
Suzanne Sprague Sr MD Global Head of Clearing |
SELL
Payment of exercise price or tax liability
|
Direct |
330
-2.21%
|
$71,610
$217.5 P/Share
|
|
Mar 15
2024
|
Suzanne Sprague Sr MD Global Head of Clearing |
BUY
Grant, award, or other acquisition
|
Direct |
561
+6.93%
|
$121,737
$217.5 P/Share
|
|
Mar 15
2024
|
Jack J Tobin MD Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
638
-1.36%
|
$138,446
$217.5 P/Share
|
|
Mar 15
2024
|
Jack J Tobin MD Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
541
+2.24%
|
$117,397
$217.5 P/Share
|
|
Mar 15
2024
|
Sunil Cutinho Chief Information Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,183
-9.74%
|
$690,711
$217.5 P/Share
|
Last 12 Months Summary
| Grant, award, or other acquisition | 169K shares |
|---|---|
| Bona fide gift | 6.06K shares |
| Open market or private sale | 556 shares |
| Open market or private purchase | 2.57K shares |
| Payment of exercise price or tax liability | 62.2K shares |
|---|---|
| Open market or private sale | 141K shares |
| Bona fide gift | 9.06K shares |